TipRanks
pc:congr

Congruence Therapeutics

Therapeutics
Congruence Therapeutics is a computationally-driven biotechnology company focused on developing transformative small molecule correctors to address diseases caused by protein misfolding. Utilizing its proprietary Revenir™ drug discovery platform, Congruence is advancing a pipeline targeting high-value, genetically validated, and difficult-to-drug conditions such as MC4R-deficient genetic obesity, GBA1-driven Parkinson's disease, and Alpha-1 Antitrypsin Deficiency. The company collaborates with large pharmaceutical partners to discover treatments for solid tumors and metabolic diseases, leveraging its innovative approach to drug discovery.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$72M
Total Amount Raised$72M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$40M
Latest Funding Amount$40M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 19, 2026
Investment
$39.50M
―
Sep 04, 2025
Investment
$32.00M
―

Investors

Investor Name
Funding Round
OrbiMed
Investment
Amplitude Ventures
Investment
Investissement Quebec
Investment
FSTQ
Investment
Lumira
Investment
BDC Capital's Thrive Venture Fund
Investment
Driehaus
Investment
Silver Arc
Investment

Similar Companies

A snapshot of private companies similar to Congruence Therapeutics, helping you discover and navigate related company profiles.
PC:HUMANHuman Longevity Inc
PC:IMPREImpress
PC:PAQTHPAQ Therapeutics
PC:CERTICertify

Related News and Analysis

Congruence Therapeutics Courts Investors at Bloom Burton Healthcare Conference

Congruence Therapeutics Courts Investors at Bloom Burton Healthcare Conference

New updates have been reported about Congruence Therapeutics. Congruence Therapeutics will use its participation at the 2026 Bloom...
6M ago
CONGR
Congruence Therapeutics Targets Investors at Needham Virtual Healthcare Conference

Congruence Therapeutics Targets Investors at Needham Virtual Healthcare Conference

New updates have been reported about Congruence Therapeutics. Congruence Therapeutics will seek to deepen its investor engagement at...
6M ago
CONGR
Congruence Therapeutics Raises $39.5M to Advance Protein-Correcting Obesity and Neurodegeneration Drugs

Congruence Therapeutics Raises $39.5M to Advance Protein-Correcting Obesity and Neurodegeneration Drugs

New updates have been reported about Congruence Therapeutics. Congruence Therapeutics has secured $39.5 million in new financing to...
7M ago
CONGR
Congruence Therapeutics Starts First-in-Human Trial of MC4R Obesity Drug CGX-926

Congruence Therapeutics Starts First-in-Human Trial of MC4R Obesity Drug CGX-926

New updates have been reported about Congruence Therapeutics. Congruence Therapeutics has initiated first-in-human dosing in its Phase 1/1b...
7M ago
CONGR
Congruence Therapeutics Expands Ono Partnership, Advances Neurology and Immunology Pipeline

Congruence Therapeutics Expands Ono Partnership, Advances Neurology and Immunology Pipeline

New updates have been reported about Congruence Therapeutics. Congruence Therapeutics has expanded its multi-target research alliance with Ono...
7M ago
CONGR
MasterClass Debuts ‘Other People’s Business’ Podcast to Deepen Engagement and Brand Reach

MasterClass Debuts ‘Other People’s Business’ Podcast to Deepen Engagement and Brand Reach

New updates have been reported about MasterClass. MasterClass is expanding beyond its core subscription video platform with the...
11m ago
MCLSS
Terra Security Earns Fast Company Innovation Nod for AI-Driven Offensive Security Platform

Terra Security Earns Fast Company Innovation Nod for AI-Driven Offensive Security Platform

New updates have been reported about Terra Security. Terra Security has been named to Fast Company’s 2026 Next...
11m ago
TERRA
Chronograph launches Claude plugins to automate core private capital workflows

Chronograph launches Claude plugins to automate core private capital workflows

New updates have been reported about Chronograph. Chronograph has expanded its AI offering with new Claude plugins that...
35m ago
CHRON
SignSplit Raises $400 Million Strategic Seed at $1 Billion Valuation to Build Signed-Data Infrastructure

SignSplit Raises $400 Million Strategic Seed at $1 Billion Valuation to Build Signed-Data Infrastructure

New updates have been reported about SignSplit. SignSplit PBC has emerged from stealth with a $400 million strategic...
59m ago
SIG2L
Nscale Adds Veteran Board Director Amy Banse to Strengthen Governance and Compensation Oversight

Nscale Adds Veteran Board Director Amy Banse to Strengthen Governance and Compensation Oversight

New updates have been reported about Nscale. Nscale has expanded its board by appointing Amy Banse, a veteran...
2h ago
NSC00